Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx

被引:74
作者
Chernock, Rebecca D. [1 ]
Wang, Xiaowei [2 ,3 ]
Gao, Ge [3 ]
Lewis, James S., Jr. [1 ,2 ]
Zhang, Qin [4 ]
Thorstad, Wade L. [3 ]
El-Mofty, Samir K. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63130 USA
[3] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63110 USA
关键词
CDKN2A(p16); CDKN1A(p21); human papillomavirus; in situ hybridization; larynx; PCR; RISK HUMAN-PAPILLOMAVIRUS; IN-SITU HYBRIDIZATION; OROPHARYNGEAL CANCER; FAVORABLE PROGNOSIS; TONSILLAR CARCINOMA; P16; PROTEIN; HPV; P21; LESIONS; DNA;
D O I
10.1038/modpathol.2012.159
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although a strong etiologic relationship between human papillomavirus (HPV) and a majority of oropharyngeal squamous cell carcinomas has been established, the role of HPV in non-oropharyngeal head and neck carcinomas is much less clear. Here, we investigated the prevalence and clinicopathologic significance of HPV and its reported biomarkers, CDKN2A(p16) and CDKN1A(p21), in laryngeal squamous cell carcinomas in patients treated either with primary surgery and postoperative radiation or with definitive radiation-based therapy. Nearly all of 76 tumors were keratinizing and none displayed the nonkeratinizing morphology that is typically associated with HPV infection in the oropharynx. However, CDKN2A(p16) immunohistochemistry was positive in 21 cases (28%) and CDKN1A(p21) in 34 (45%). CDKN2A(p16) and CDKN1A(p21) status strongly correlated with each other (P=0.0038). Yet, only four cases were HPV positive by DNA in situ hybridization or by reverse transcriptase PCR E6/E7 mRNA (all four were CDKN2A(p16) and CDKN1A(p21) positive). Unexpectedly, 9 additional tumors out of 20 CDKN2A(p16) positive cases harbored high-risk HPV DNA by PCR. For further investigation of this unexpected result, in situ hybridization for E6/E7 mRNA was performed on these nine cases and all were negative, confirming the absence of transcriptionally active virus. Patients with CDKN1A(p21)-positive tumors did have better overall survival (69% at 3 years) than those with CDKN1A(p21)-negative tumors (51% at 3 years) (P=0.045). There was also a strong trend towards better overall survival in the CDKN2A(p16)-positive group (P=0.058). Thus, it appears that the role of HPV is more complex in the larynx than in the oropharynx, and that CDKN2A(p16) and CDKN1A(p21) expression may not reflect HPV-driven tumors in most cases. Because of this, CDKN2A(p16) should not be used as a definitive surrogate marker of HPV-driven tumors in the larynx. Modern Pathology (2013) 26, 223-231; doi:10.1038/modpathol.2012.159; published online 21 September 2012
引用
收藏
页码:223 / 231
页数:9
相关论文
共 37 条
[11]   High incidence of high-risk HPV in benign and malignant lesions of the larynx [J].
Duray, Anaelle ;
Descamps, Geraldine ;
Arafa, Mohammad ;
Decaestecker, Christine ;
Remmelink, Myriam ;
Sirtaine, Nicolas ;
Ernoux-Neufcoeur, Perle ;
Mutijima, Eugene ;
Somja, Joan ;
Depuydt, Christophe E. ;
Delvenne, Philippe ;
Saussez, Sven .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (01) :51-59
[12]   Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: Characterization of a distinct phenotype [J].
El-Mofty, SK ;
Patil, S .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2006, 101 (03) :339-345
[13]   Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein [J].
Funk, JO ;
Waga, S ;
Harry, JB ;
Espling, E ;
Stillman, B ;
Galloway, DA .
GENES & DEVELOPMENT, 1997, 11 (16) :2090-2100
[14]  
Fury MG, 2010, HEAD NECK-J SCI SPEC, V33, P1340
[15]  
García-Milián R, 1998, ACTA OTO-LARYNGOL, V118, P754
[16]   P21Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis [J].
Hafkamp, Harriet C. ;
Mooren, Jeroen J. ;
Claessen, Sandra M. H. ;
Klingenberg, Boris ;
Voogd, Adri C. ;
Bot, Fredrik J. ;
Klussmann, J. Peter ;
Hopman, Anton H. N. ;
Manni, Johannes J. ;
Kremer, Bernd ;
Ramaekers, Frans C. S. ;
Speel, Ernst-Jan M. .
MODERN PATHOLOGY, 2009, 22 (05) :686-698
[17]   Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer [J].
Jeannon, JP ;
Soames, J ;
Lunec, J ;
Awwad, S ;
Ashton, V ;
Wilson, JA .
CLINICAL OTOLARYNGOLOGY, 2000, 25 (01) :23-27
[18]   HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation [J].
Kim, Se-Heon ;
Koo, Bon-Seok ;
Kang, Suki ;
Park, Kyeongmee ;
Kim, Haeryoung ;
Lee, Kyung Ryul ;
Lee, Moo Joo ;
Kim, Jong Man ;
Choi, Eun Chang ;
Cho, Nam Hoon .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) :1418-1425
[19]   Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus [J].
Klussmann, JP ;
Gültekin, E ;
Weissenborn, SJ ;
Wieland, U ;
Dries, V ;
Dienes, HP ;
Eckel, HE ;
Pfister, HJ ;
Fuchs, PG .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (03) :747-753
[20]   Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review [J].
Kreimer, AR ;
Clifford, GM ;
Boyle, P ;
Franceschi, S .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) :467-475